[{"AccountsPayableCurrent_0_Q3_USD":1742000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8450000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1136000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-26000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":4000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":4819000.0,"OtherLiabilitiesCurrent_0_Q3_USD":20671000.0,"OtherAssetsNoncurrent_0_Q3_USD":3209000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.081,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3068000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":8967000.0,"OperatingLeasePayments_3_Q3_USD":2400000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":57000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3160000.0,"OperatingLeaseLiability_0_Q3_USD":3217000.0,"OperatingLeaseExpense_3_Q3_USD":2400000.0,"OperatingLeaseExpense_1_Q3_USD":800000.0,"OperatingExpenses_3_Q3_USD":183697000.0,"OperatingExpenses_1_Q3_USD":65486000.0,"NonoperatingIncomeExpense_3_Q3_USD":-39530000.0,"NonoperatingIncomeExpense_1_Q3_USD":-13751000.0,"NetIncomeLoss_3_Q3_USD":-212001000.0,"OperatingLeasePayments_1_Q3_USD":800000.0,"ProfitLoss_3_Q3_USD":-212001000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6976000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":8967000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":337000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":229543.0,"StockholdersEquity_0_Q3_USD":255977000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":123.78,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":126.23,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":203.57,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":39.09,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":86.43,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4705515.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":176800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":914179.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":237872.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":47518.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":53.51,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2637621.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":151700000.0,"ShareBasedCompensation_3_Q3_USD":41580000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":10557000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":7391000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1170246000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":114377000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":39430000.0,"NetIncomeLoss_1_Q3_USD":-71846000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-112769000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1136000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":8967000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.84,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.97,"Depreciation_3_Q3_USD":880000.0,"Depreciation_1_Q3_USD":320000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_3_Q3_USD":5000000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":1000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":2561000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-104938000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":713212000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":713212000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":4239000.0,"AssetsCurrent_0_Q3_USD":721662000.0,"Assets_0_Q3_USD":731847000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4705515.0,"AmortizationOfFinancingCosts_3_Q3_USD":5322000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":41580000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":13657000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":41580000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13657000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1426187000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":17552000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.003,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":36387560.0,"GainLossOnTerminationOfLease_3_Q3_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":0.0,"LiabilitiesNoncurrent_0_Q3_USD":354585000.0,"LiabilitiesCurrent_0_Q3_USD":121285000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":731847000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":148000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":795000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2570000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3365000.0,"InvestmentIncomeNonoperating_3_Q3_USD":130000.0,"InvestmentIncomeNonoperating_1_Q3_USD":38000.0,"InterestPaidNet_3_Q3_USD":0.0,"InterestExpense_3_Q3_USD":5322000.0,"InterestExpense_1_Q3_USD":1835000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1471000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":-22228000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-2127000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1625000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-3117000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-669000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-212670000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-71846000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":68440000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":25736000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":36297766.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]